先天性好中球減少症治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3133)
◆英語タイトル:Global Congenital Neutropenia Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3133
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥518,700見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥778,050見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,037,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、先天性好中球減少症治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(抗生物質、顆粒球コロニー刺激因子(G-CSF)、抗真菌薬)、用途別市場規模(小売薬局、病院薬局、オンライン薬局、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・先天性好中球減少症治療の市場動向
・企業の競争状況、市場シェア
・先天性好中球減少症治療の種類別市場規模(抗生物質、顆粒球コロニー刺激因子(G-CSF)、抗真菌薬)
・先天性好中球減少症治療の用途別市場規模(小売薬局、病院薬局、オンライン薬局、その他)
・先天性好中球減少症治療の北米市場規模2016-2027(アメリカ、カナダ)
・先天性好中球減少症治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・先天性好中球減少症治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・先天性好中球減少症治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・先天性好中球減少症治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Baxter International、Teva Pharmaceutical, Inc.、Amgen、Sanofi、Novartis AG、Teva Pharmaceuticals Industries Ltd.、Biogenomics Limited、Dr. Reddy’s Laboratory Ltd.、Apotex、Intas Pharmaceuticals Ltd.)
・結論
【レポートの概要】

Congenital neutropenia occurs when an individual has low levels of neutrophils, a type of white blood cells. Neutrophils are made in the bone marrow, which is the spongy tissue found in larger bones such as the vertebrae, ribs, and pelvis. The congenital neutropenia treatment include antibiotics, antifungal drugs and so on.

Market Analysis and Insights: Global Congenital Neutropenia Treatment Market
The global Congenital Neutropenia Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Congenital Neutropenia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Congenital Neutropenia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Congenital Neutropenia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Congenital Neutropenia Treatment market.

Global Congenital Neutropenia Treatment Scope and Market Size
Congenital Neutropenia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Congenital Neutropenia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antibiotics
Granulocyte -Colony- Stimulating Factor (G-CSF)
Antifungal Drugs

Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Baxter International
Teva Pharmaceutical, Inc.
Amgen
Sanofi
Novartis AG
Teva Pharmaceuticals Industries Ltd.
Biogenomics Limited
Dr. Reddy’s Laboratory Ltd.
Apotex
Intas Pharmaceuticals Ltd.

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Congenital Neutropenia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 Granulocyte -Colony- Stimulating Factor (G-CSF)
1.2.4 Antifungal Drugs
1.3 Market by Application
1.3.1 Global Congenital Neutropenia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Congenital Neutropenia Treatment Market Perspective (2016-2027)
2.2 Congenital Neutropenia Treatment Growth Trends by Regions
2.2.1 Congenital Neutropenia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Congenital Neutropenia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Congenital Neutropenia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Congenital Neutropenia Treatment Industry Dynamic
2.3.1 Congenital Neutropenia Treatment Market Trends
2.3.2 Congenital Neutropenia Treatment Market Drivers
2.3.3 Congenital Neutropenia Treatment Market Challenges
2.3.4 Congenital Neutropenia Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Congenital Neutropenia Treatment Players by Revenue
3.1.1 Global Top Congenital Neutropenia Treatment Players by Revenue (2016-2021)
3.1.2 Global Congenital Neutropenia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Congenital Neutropenia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Congenital Neutropenia Treatment Revenue
3.4 Global Congenital Neutropenia Treatment Market Concentration Ratio
3.4.1 Global Congenital Neutropenia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Congenital Neutropenia Treatment Revenue in 2020
3.5 Congenital Neutropenia Treatment Key Players Head office and Area Served
3.6 Key Players Congenital Neutropenia Treatment Product Solution and Service
3.7 Date of Enter into Congenital Neutropenia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Congenital Neutropenia Treatment Breakdown Data by Type
4.1 Global Congenital Neutropenia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Congenital Neutropenia Treatment Forecasted Market Size by Type (2022-2027)

5 Congenital Neutropenia Treatment Breakdown Data by Application
5.1 Global Congenital Neutropenia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Congenital Neutropenia Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Congenital Neutropenia Treatment Market Size (2016-2027)
6.2 North America Congenital Neutropenia Treatment Market Size by Type
6.2.1 North America Congenital Neutropenia Treatment Market Size by Type (2016-2021)
6.2.2 North America Congenital Neutropenia Treatment Market Size by Type (2022-2027)
6.2.3 North America Congenital Neutropenia Treatment Market Size by Type (2016-2027)
6.3 North America Congenital Neutropenia Treatment Market Size by Application
6.3.1 North America Congenital Neutropenia Treatment Market Size by Application (2016-2021)
6.3.2 North America Congenital Neutropenia Treatment Market Size by Application (2022-2027)
6.3.3 North America Congenital Neutropenia Treatment Market Size by Application (2016-2027)
6.4 North America Congenital Neutropenia Treatment Market Size by Country
6.4.1 North America Congenital Neutropenia Treatment Market Size by Country (2016-2021)
6.4.2 North America Congenital Neutropenia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Congenital Neutropenia Treatment Market Size (2016-2027)
7.2 Europe Congenital Neutropenia Treatment Market Size by Type
7.2.1 Europe Congenital Neutropenia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Congenital Neutropenia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Congenital Neutropenia Treatment Market Size by Type (2016-2027)
7.3 Europe Congenital Neutropenia Treatment Market Size by Application
7.3.1 Europe Congenital Neutropenia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Congenital Neutropenia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Congenital Neutropenia Treatment Market Size by Application (2016-2027)
7.4 Europe Congenital Neutropenia Treatment Market Size by Country
7.4.1 Europe Congenital Neutropenia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Congenital Neutropenia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Congenital Neutropenia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Congenital Neutropenia Treatment Market Size by Type
8.2.1 Asia-Pacific Congenital Neutropenia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Congenital Neutropenia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Congenital Neutropenia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Congenital Neutropenia Treatment Market Size by Application
8.3.1 Asia-Pacific Congenital Neutropenia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Congenital Neutropenia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Congenital Neutropenia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Congenital Neutropenia Treatment Market Size by Region
8.4.1 Asia-Pacific Congenital Neutropenia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Congenital Neutropenia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Congenital Neutropenia Treatment Market Size (2016-2027)
9.2 Latin America Congenital Neutropenia Treatment Market Size by Type
9.2.1 Latin America Congenital Neutropenia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Congenital Neutropenia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Congenital Neutropenia Treatment Market Size by Type (2016-2027)
9.3 Latin America Congenital Neutropenia Treatment Market Size by Application
9.3.1 Latin America Congenital Neutropenia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Congenital Neutropenia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Congenital Neutropenia Treatment Market Size by Application (2016-2027)
9.4 Latin America Congenital Neutropenia Treatment Market Size by Country
9.4.1 Latin America Congenital Neutropenia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Congenital Neutropenia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Congenital Neutropenia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Congenital Neutropenia Treatment Market Size by Type
10.2.1 Middle East & Africa Congenital Neutropenia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Congenital Neutropenia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Congenital Neutropenia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Congenital Neutropenia Treatment Market Size by Application
10.3.1 Middle East & Africa Congenital Neutropenia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Congenital Neutropenia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Congenital Neutropenia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Congenital Neutropenia Treatment Market Size by Country
10.4.1 Middle East & Africa Congenital Neutropenia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Congenital Neutropenia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Baxter International
11.1.1 Baxter International Company Details
11.1.2 Baxter International Business Overview
11.1.3 Baxter International Congenital Neutropenia Treatment Introduction
11.1.4 Baxter International Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.1.5 Baxter International Recent Development
11.2 Teva Pharmaceutical, Inc.
11.2.1 Teva Pharmaceutical, Inc. Company Details
11.2.2 Teva Pharmaceutical, Inc. Business Overview
11.2.3 Teva Pharmaceutical, Inc. Congenital Neutropenia Treatment Introduction
11.2.4 Teva Pharmaceutical, Inc. Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.2.5 Teva Pharmaceutical, Inc. Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Congenital Neutropenia Treatment Introduction
11.3.4 Amgen Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.3.5 Amgen Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Congenital Neutropenia Treatment Introduction
11.4.4 Sanofi Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Congenital Neutropenia Treatment Introduction
11.5.4 Novartis AG Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.5.5 Novartis AG Recent Development
11.6 Teva Pharmaceuticals Industries Ltd.
11.6.1 Teva Pharmaceuticals Industries Ltd. Company Details
11.6.2 Teva Pharmaceuticals Industries Ltd. Business Overview
11.6.3 Teva Pharmaceuticals Industries Ltd. Congenital Neutropenia Treatment Introduction
11.6.4 Teva Pharmaceuticals Industries Ltd. Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.6.5 Teva Pharmaceuticals Industries Ltd. Recent Development
11.7 Biogenomics Limited
11.7.1 Biogenomics Limited Company Details
11.7.2 Biogenomics Limited Business Overview
11.7.3 Biogenomics Limited Congenital Neutropenia Treatment Introduction
11.7.4 Biogenomics Limited Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.7.5 Biogenomics Limited Recent Development
11.8 Dr. Reddy’s Laboratory Ltd.
11.8.1 Dr. Reddy’s Laboratory Ltd. Company Details
11.8.2 Dr. Reddy’s Laboratory Ltd. Business Overview
11.8.3 Dr. Reddy’s Laboratory Ltd. Congenital Neutropenia Treatment Introduction
11.8.4 Dr. Reddy’s Laboratory Ltd. Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.8.5 Dr. Reddy’s Laboratory Ltd. Recent Development
11.9 Apotex
11.9.1 Apotex Company Details
11.9.2 Apotex Business Overview
11.9.3 Apotex Congenital Neutropenia Treatment Introduction
11.9.4 Apotex Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.9.5 Apotex Recent Development
11.10 Intas Pharmaceuticals Ltd.
11.10.1 Intas Pharmaceuticals Ltd. Company Details
11.10.2 Intas Pharmaceuticals Ltd. Business Overview
11.10.3 Intas Pharmaceuticals Ltd. Congenital Neutropenia Treatment Introduction
11.10.4 Intas Pharmaceuticals Ltd. Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.10.5 Intas Pharmaceuticals Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 先天性好中球減少症治療の世界市場規模・現状・予測2021年-2027年(Global Congenital Neutropenia Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。